We use cookies. Find out more about it here. By continuing to browse this site you are agreeing to our use of cookies.
#alert
Back to search results

Manager, FP&A, Business Development & Strategy

Alnylam Pharmaceuticals
United States, Massachusetts, Cambridge
675 West Kendall Street (Show on map)
Nov 13, 2024

This role is considered Hybrid.

Overview

We are seeking a dynamic and experienced Manager of Business Development Strategy Finance. Reporting to the Head of Business Development & Corporate Development Strategy Finance, this role involves financial modeling, forecasting, and analysis efforts to support the company's internal portfolio and external innovation strategies. The individual will contribute to ensuring the organization's financial goals align with strategic decisions, helping to support Business & Corporate development strategy while reducing financial risk.

Key Responsibilities

Strategic Business Partnering

  • Forge strong partnerships across the enterprise, including cross functional project teams,
  • to assess financial viability of strategic internal or external opportunities.
  • Liase with Accounting to ensure deal models support long term accounting needs
  • Ensure contractual points for external business development transactions are well understood across finance stakeholders and leadership team (tax, treasury, FP&A, accounting, audit)
  • Support the financial integration of new business opportunities by liaising with Alliance Management and other cross-functional team members

Modeling Capabilities

  • Develop, implement and maintain effective financial tools and processes to support the business and corporate development teams as they assess potential inbound and outbound licensing, partnering, and M&A transactions
  • Build and maintain financial models supporting transactions, accurately reflecting contractual points
  • Ensure consistent use of assumptions across internal and external asset valuations

Forecasting, Planning & Analysis

  • Coordinate with the other Finance Business Partners to ensure all financial analyses are accurately assessed in the context of internal planning norms (Commercial and Med Affairs, TOQ, R&D, G&A and LRP).
  • Support financial planning, forecasting, and analysis for business development initiatives.
  • Develop presentations of complex financial analysis in a clear and effective way for Senior Leadership and Deal Teams.
  • Conduct regular financial assumption reviews and highlight any potential financial risks.

Qualifications

Education/Experience

  • Bachelor's degree in Finance, Accounting, Business or related field is required. A CFA, MBA or other related advance degree is a plus.
  • A minimum of 6 years of experience in finance or a related field, preferably with a focus on business development finance or strategic planning in life sciences.

Technical

  • Strong understanding of financial models, valuations, and business proposals.
  • Demonstrated ability to translate complex financial information and assumptions into effective presentations
  • Proficient in financial software and Microsoft Office suite

Other Skills & Interpersonal Behaviors

  • Excellent time management and ability to prioritize and remain organized in fast-paced, dynamic environment
  • Intellectually curious and willing to offer insights or challenge assumptions appropriately
  • Strong collaboration skills, with an ability to inspire and motivate teams
  • Excellent analytical, strategic planning, and problem-solving skills
  • Ability to work as a member of the deal team, as well as an individual contributor
  • Exceptional communication skills and excellent attention to detail
  • Ability to influence and build relationships at all levels of the organization

About Alnylam:Alnylam Pharmaceuticals (Nasdaq: ALNY) has led the translation of RNA interference (RNAi) into a whole new class of innovative medicines with the potential to transform the lives of people afflicted with rare and more prevalent diseases. Based on Nobel Prize-winning science, RNAi therapeutics represent a powerful, clinically validated approach to treating diseases at their genetic source by "interfering" with mRNA that cause or contribute to disease. Since our founding in 2002, Alnylam has led the RNAi Revolution and continues to turn scientific possibility into reality.

Our culture:Our people-first culture is guided by our core values: fiercely innovative, open culture, purposeful urgency, passion for excellence, and commitment to people, and these values influence how we work and the business decisions we make. Thanks to feedback from our employees over the years, we've been fortunate to be named a top employer around the world. Alnylam is extremely proud to have been recognized as the #1 Large Employer by Boston Globe Top Places to Work in 2023 for the third consecutive year, one of Science Magazine's Top Biopharma Employers, one of America's Most Responsible Companies for 2024 by Newsweek, a Fast Company Best Workplace for Innovators, and a Great Place to Work in Canada, France, Italy, Spain, Switzerland, and UK - among others.

At Alnylam, we commit to an inclusive recruitment process and equal employment opportunity. We are dedicated to building an environment where employees can feel that they belong, can bring their authentic selves to work, and achieve to their full potential. By empowering employees to embrace their unique differences at work, our business grows stronger with advanced and original thinking, allowing us to bring groundbreaking medicines to patients. Qualified applicants will receive consideration for employment without regard to their race, color, religion, age, sex, sexual orientation, gender identity or expression, national origin, ethnicity, marital status, protected veteran status, disability, or any other characteristics prohibited by law.

>
Applied = 0

(web-69c66cf95d-jtnrk)